Aberdare Ventures is a San Francisco-based venture capital firm founded in 1999, focused exclusively on transformational companies that enable more efficient, less costly, and smarter healthcare. The firm invests in early-stage healthcare opportunities, including digital health and life sciences.
36% of their portfolio is in Healthcare. Average disclosed round size is $24.7M (across 14 rounds with reported amounts).
Portfolio
12
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
BB
Brett Battles
General Partner
DK
Daniel Kisner
Venture Partner/Partner
MK
Mohit Kaushal
Partner
SH
Sami Hamade
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Cricket Health | Series A | $24M | Sep 2018 |
 Gravie | Series C | $14.1M | Jul 2017 |
| Gravie | Series B | $12.5M | Apr 2015 |
| JJiff | Series B | $18M | Sep 2014 |
| Gravie | Series A | $10.5M | Mar 2014 |
 Wello | Seed | $1M | Nov 2012 |
 Wello | Seed | $1M | Nov 2012 |
| AAnacor Pharmaceuticals | Unknown | $50M | Jan 2009 |
| AAblation Frontiers | Series C | $21.8M | Jan 2007 |
| CConatus | Series A | $22M | Jan 2007 |
| CConatus Pharmaceuticals | Series B | $20M | — |
| AAutonomic Technologies | Series D | $43.2M | — |
| AAnacor Pharmaceuticals, Inc. | Unknown | $50M | — |
| NNevro Corp | Unknown | $58M | — |
Top Co-Investors
General Catalyst3 shared
FirstMark Capital3 shared
Venrock3 shared
Split Rock Partners2 shared
Rho Capital Partners2 shared
Roche Venture Fund2 shared
Advent International2 shared
Kleiner Perkins2 shared
Mohr Davidow Ventures2 shared
Morado Ventures2 shared
Novartis Venture Fund2 shared
Lifeforce Capital1 shared
iSeed1 shared
Seven Peaks Ventures1 shared
Liquid 2 Ventures1 shared
First Round Capital1 shared
Oak HC/FT1 shared
Nexus Venture Partners1 shared
Index Ventures1 shared
BoxGroup1 shared
Last updated: 8 September 2026